Prostate Cancer Trial, Recruiting NCT07162987 Sponsor: Odense University Hospital Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07162987
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with prostate cancer
  • People who are at least 18 years old
  • People who are receiving androgen deprivation therapy and radiation therapy as their treatment
  • People who live in Vejle Municipality or Esbjerg Municipality in Denmark
  • People who are able to attend a residential prehabilitation program during week 43 or week 50 of 2025, as well as ongoing physical exercise sessions in their local municipality
  • People who are willing to take part in a research study
  • People who are suited to participating in group sessions (confirm with trial site)
  • People who can read and communicate in Danish
  • People who are able to manage their own personal hygiene and medications during a 4-day residential stay

Who may not be able to join:

  • People who do not meet all of the inclusion criteria listed above are not eligible to participate in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Odense University Hospital
Registry
ClinicalTrials.gov
Start date
4 August 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Change from baseline to follow-up in quality of life measured by EORTC-QLQ-C30

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov